表紙
市場調查報告書

高頻導管:醫療設備的開發平台評估

Radiofrequency Catheters - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 654784
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
高頻導管:醫療設備的開發平台評估 Radiofrequency Catheters - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月17日內容資訊: 英文 53 Pages
簡介

本報告提供全球高頻 (RF) 導管市場上,主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,及主要企業、組織的簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 高頻導管概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 高頻導管:臨床實驗中的開發中產品,各企業

  • 高頻導管的企業:各臨床實驗階段的開發中產品
  • 高頻導管:各臨床實驗階段的開發中產品

第5章 高頻導管市場:企業、產品概要

  • Handok Inc
    • 開發中產品及進行中的臨床實驗概要
  • Handok-Kalos Medical
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Medtronic plc
  • MicroPort Scientific Corp
  • Renal Dynamics, LLC
  • St. Jude Medical LLC
  • Suzhou SyMap Medical Ltd
  • Verve Medical, Inc.

第6章 生物學心臟瓣膜市場:目前的趨勢 (共22件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0863EPD

GlobalData's Medical Devices sector report, "Radiofrequency Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Radiofrequency Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Radiofrequency Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Radiofrequency Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Radiofrequency Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Radiofrequency Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Radiofrequency Catheters Overview 6

3 Products under Development 7

  • 3.1 Radiofrequency Catheters - Pipeline Products by Stage of Development 7
  • 3.2 Radiofrequency Catheters - Pipeline Products by Territory 8
  • 3.3 Radiofrequency Catheters - Pipeline Products by Regulatory Path 9
  • 3.4 Radiofrequency Catheters - Pipeline Products by Estimated Approval Date 10
  • 3.5 Radiofrequency Catheters - Ongoing Clinical Trials 11

4 Radiofrequency Catheters - Pipeline Products under Development by Companies 12

  • 4.1 Radiofrequency Catheters Companies - Pipeline Products by Stage of Development 12
  • 4.2 Radiofrequency Catheters - Pipeline Products by Stage of Development 13

5 Radiofrequency Catheters Companies and Product Overview 14

  • 5.1 Handok Inc Company Overview 14
    • 5.1.1 Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Handok-Kalos Medical Company Overview 16
    • 5.2.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 17
    • 5.3.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Mayo Clinic Company Overview 18
    • 5.4.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Medtronic plc Company Overview 19
    • 5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 MicroPort Scientific Corp Company Overview 27
    • 5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 Renal Dynamics, LLC Company Overview 28
    • 5.7.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.8 St. Jude Medical LLC Company Overview 29
    • 5.8.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.9 Suzhou SyMap Medical Ltd Company Overview 30
    • 5.9.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.10 Verve Medical, Inc. Company Overview 33
    • 5.10.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

6 Radiofrequency Catheters- Recent Developments 34

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 34
  • 6.2 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 36
  • 6.3 Sep 20, 2019: Terumo to increase production capacity for alliance business 37
  • 6.4 Aug 28, 2019: Medtronic announces planned leadership succession 37
  • 6.5 Aug 20, 2019: Medtronic reports first quarter financial results for 2019 39
  • 6.6 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 42
  • 6.7 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 42
  • 6.8 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results 43
  • 6.9 May 22, 2019: Results announced from two Renal Denervation Studies at EuroPCR show positive outcomes in high-risk hypertensive patients 45
  • 6.10 May 21, 2019: Terumo appoints EU based Subsidiary's Associate as the Newest Terumo Fellow 46
  • 6.11 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai 47
  • 6.12 Feb 26, 2019: Terumo to construct new facilities at its Vietnamese factory -15 billion yen investment to strengthen interventional therapeutic related production 48
  • 6.13 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 48

7 Appendix 50

  • 7.1 Methodology 50
  • 7.2 About GlobalData 53
  • 7.3 Contact Us 53
  • 7.4 Disclaimer 53

List of Tables

  • Table 1: Radiofrequency Catheters - Pipeline Products by Stage of Development
  • Table 2: Radiofrequency Catheters - Pipeline Products by Territory
  • Table 3: Radiofrequency Catheters - Pipeline Products by Regulatory Path
  • Table 4: Radiofrequency Catheters - Pipeline Products by Estimated Approval Date
  • Table 5: Radiofrequency Catheters - Ongoing Clinical Trials
  • Table 6: Radiofrequency Catheters Companies - Pipeline Products by Stage of Development
  • Table 7: Radiofrequency Catheters - Pipeline Products by Stage of Development
  • Table 8: Handok Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: 2nd Gen Renal Denervation System - Product Status
  • Table 10: 2nd Gen Renal Denervation System - Product Description
  • Table 11: 3rd Gen Renal Denervation System - Product Status
  • Table 12: 3rd Gen Renal Denervation System - Product Description
  • Table 13: Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: DENEX - Product Status
  • Table 15: DENEX - Product Description
  • Table 16: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Renal Denervation Catheter - Product Status
  • Table 18: Renal Denervation Catheter - Product Description
  • Table 19: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Pressure Wire - Product Status
  • Table 21: Pressure Wire - Product Description
  • Table 22: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Symplicity Renal Denervation System - Product Status
  • Table 24: Symplicity Renal Denervation System - Product Description
  • Table 25: Symplicity Spyral Renal Denervation Catheter - Product Status
  • Table 26: Symplicity Spyral Renal Denervation Catheter - Product Description
  • Table 27: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 28: Symplicity Renal Denervation System - A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients with Chronic Heart Failure (CHF)
  • Table 29: Symplicity Renal Denervation System - Global Prospective Registry for Sympathetic Renal Denervation in Selected Indications Through 3 Years Registry
  • Table 30: Symplicity Renal Denervation System - Renal Denervation in Treatment Resistant Hypertension
  • Table 31: Symplicity Renal Denervation System - Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients with Hypertensive Heart Disease: A Pilot Study
  • Table 32: Symplicity Renal Denervation System - Understanding the Mechanisms of Progressive Decrease in Blood Pressure after Renal Nerve Ablation
  • Table 33: Symplicity Spyral Renal Denervation Catheter - A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries
  • Table 34: Symplicity Spyral Renal Denervation Catheter - Combined Treatment with Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients with Acute Coronary Syndromes
  • Table 35: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
  • Table 36: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy: SPYRAL HTN-ON MED
  • Table 37: Symplicity Spyral Renal Denervation Catheter - Renal Nerve Denervation in Patients with Hypertension and Paroxysmal and Persistent Atrial Fibrillation
  • Table 38: Symplicity Spyral Renal Denervation Catheter - Symplicity Spyral Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-hypertensive Medication
  • Table 39: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: FlashPoint Renal Artery RF Ablation Catheter - Product Status
  • Table 41: FlashPoint Renal Artery RF Ablation Catheter - Product Description
  • Table 42: Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: ReDy Renal Denervation System - Product Status
  • Table 44: ReDy Renal Denervation System - Product Description
  • Table 45: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Third Generation EnligHTN Renal Denervation System - Product Status
  • Table 47: Third Generation EnligHTN Renal Denervation System - Product Description
  • Table 48: Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: SyMapCath I Catheter - Product Status
  • Table 50: SyMapCath I Catheter - Product Description
  • Table 51: Suzhou SyMap Medical Ltd - Ongoing Clinical Trials Overview
  • Table 52: SyMapCath I Catheter - A Prospective, Multicenter, Blind, Randomized and Controlled Trial of Selected Renal Denervation by Renal Nerve Mapping for the Treatment of Hypertension (HTN) in the Absence of Antihypertensive Medications (OFF MED)
  • Table 53: SyMapCath I Catheter - A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial)
  • Table 54: Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Verve Medical System - Product Status
  • Table 56: Verve Medical System - Product Description
  • Table 57: Glossary

List of Figures

  • Figure 1: Radiofrequency Catheters - Pipeline Products by Stage of Development
  • Figure 2: Radiofrequency Catheters - Pipeline Products by Territory
  • Figure 3: Radiofrequency Catheters - Pipeline Products by Regulatory Path
  • Figure 4: Radiofrequency Catheters - Pipeline Products by Estimated Approval Date
  • Figure 5: Radiofrequency Catheters - Ongoing Clinical Trials
Back to Top